Virtual Meetings, Food and Drug Administration (FDA)

TTB Seeking Public Input on Potential Alcoholic Beverage Labeling Changes

Troutman Pepper on 2/8/2024

As we previously reported, the Treasury Department released a 2022 report on Competition in the Markets for Beer, Wine, and Spirits (the Competition Report) recommending, in part, that the Alcohol and Tobacco Tax and Trade...more

What’s On the Radar of In-House Attorneys?

Gardner Law on 10/20/2022

Here are key points made by the all general counsel panel on various topics. Key Points: Physician remunerative relationships, OIG Special Fraud Alert on Speaker Programs, & Virtual Interactions...more

FDA’s Remote Regulatory Assessments Q&A Draft Guidance Document Explains the Regulated Industry’s New Virtual Reality

Wiley Rein LLP on 8/31/2022

The U.S. Food and Drug Administration (FDA or Agency) recently announced the availability of a new draft guidance titled “Conducting Remote Regulatory Assessments: Questions and Answers” (RRA Draft Guidance). Remote...more

Potential AI/ML Learnings to Come from FDA Public Advisory Committee Meeting on Skin Lesion Analyzer Technology in Late July

Goodwin on 6/22/2022

On July 28, 2022, the U.S. Food and Drug Administration (FDA) will hold a public advisory committee meeting to discuss skin lesion analyzer (SLA) technology and its application to detecting skin cancers in various patient...more

COVID-19 Insights Week In Review — April 8, 2020

Mintz - ML Strategies on 4/8/2020

As the coronavirus pandemic spreads across the nation, your team at ML Strategies continues to monitor legislative and regulatory updates at the federal and state level. Each week, ML Strategies will provide weekly updates...more

Virtual Meetings › Food and Drug Administration (FDA)

TTB Seeking Public Input on Potential Alcoholic Beverage Labeling Changes

What’s On the Radar of In-House Attorneys?

FDA’s Remote Regulatory Assessments Q&A Draft Guidance Document Explains the Regulated Industry’s New Virtual Reality

Potential AI/ML Learnings to Come from FDA Public Advisory Committee Meeting on Skin Lesion Analyzer Technology in Late July

COVID-19 Insights Week In Review — April 8, 2020

"My best business intelligence, in one easy email…"